Saint Alphonsus Health System

Dr. Alan Langerak on Clinical Research

Major Research Program Coming to the Saint Alphonsus Cancer Care Center

Alan Langerak, MDOncology is one of the most rapidly changing fields of medicine. Research and clinical trials drive these changes, but patients in Boise have had relatively limited access to exciting new trials because of our distance from major academic centers where these trials are typically formed. That is all changing now.

The Saint Alphonsus Cancer Care Center has entered into an agreement with the Michigan Cancer Research Consortium CCOP (Community Clinical Oncology Program) which will allow the oncologists of the Cancer Care Center to place patients on the same clinical trials that are available to patients at academic centers. The Michigan CCOP is one of only 50 community based research programs that is supported by the National Cancer Institute NCI), and has over 100 trials available to patients with various solid tumors and hematologic malignancies. At the time of this writing, there are 14 clinical trials available for patients with breast cancer, 13 for patients with lung cancer, and 16 trials for patients with various gynecologic malignancies. There are even 9 studies currently offered for supportive care/side effect management.

The majority of these trials are run by the national cooperative groups, such as ECOG (Eastern Cooperative Oncology Group), SWOG (Southwest Oncology Group), NSABP (National Surgical Adjuvant Breast and Bowel Program), and RTOG (Radiation Therapy Oncology Group). The availability of these clinical trials locally will allow the Cancer Care Center oncologists (medical, radiation, and gynecologic) to treat patients with cutting edge therapy, without the need to send them to Salt Lake City, Seattle, Portland, or elsewhere. Patients can now remain here in the Treasure Valley, and receive the same therapy they would have received in a university setting, without having to leave the comfort of their family and friends.

Access to these clinical trials is wonderful news for our patients. To discuss clinical trial options with an oncologist, call 367-ONCS or to speak with our research staff please call 367-6816